Science and Innovation Thought-leaders â€¦
The Science Symposium of the School of Thinking is a world class panel of science and R&D thought-leaders and they review the SOT strategic initiatives for 2016/2017.
The School of Thinking 2016 Problem is: What is a better unit of innovation? The next symposium is in March.
The seven members who meet quarterly in symposium are Sir Gus Nossal, Professor David Penington, Dr Graham Mitchell, Dr John Stocker, Mr Michael Taylor, Mr Peter Turvey and Ms Maria Deveson Crabbe.
Sir Gustav Nossal AC CBE, FAA, FRS
Gustav Nossal took his Ph.D. at The Walter and Eliza Hall Institute of Medical Research. Sir Gus has been President of the Australian Academy of Science (1994-1998); a member of the Prime Ministerâ€™s Science, Engineering and Innovation Council (1989-1998); and Chairman of the Strategic Advisory Council of the Bill and Melinda Gates Childrenâ€™s Vaccine Program (1998-2003). Nossal was knighted in 1977, made a Companion of the Order of Australia in 1989 and appointed Australian of the Year in 2000. Since 2010, Nossal has been Chairman of the Gates Foundation’s Discovery Expert Group, charged with developing longer-term research strategies.
Professor David Penington AC, DM, MA(Oxon), FRCP, FRACP, FRCPA
After graduating in medicine at Oxford David Penington returned to Melbourne as Professor of Medicine at the University of Melbourne then Dean of the Faculty of Medicine then Vice-Chancellor of the University of Melbourne for eight years from 1988. He was Chairman of the National AIDS Task Force (1983-87). He was Chairman of the Board of Cochlear Ltd from 1995 to 2002. His autobiography â€œMaking Waves: Medicine, Public Health, Universities and Beyondâ€ published by Melbourne University Press July 2010.
Dr John Stocker AO MB BS BMedSc PhD FRACP FTSE
John Stocker has a distinguished career in pharmaceutical research and extensive experience in management of research and development and in its commercialisation. Stocker is a Director of Telstra and a Board member of Wine Victoria. He was Chief Executive of CSIRO and later the Australian Governmentâ€™s Chief Scientist and a member of the Board of The Walter and Eliza Hall Institute for Medical Research. He was appointed an Officer in the Order of Australia in June 1999 and was awarded the Centenary Medal in 2003.
Dr Graham Mitchell AO RDA BVSc FACVSc PhD FTSE FAA
At The Walter and Eliza Hall Institute of Medical Research (WEHI) Graham Mitchell made discoveries in immunology obtaining his PhD in 1969. In 1990 he was appointed Director of the prestigious Royal Melbourne Zoological Gardens. Recognised as one of Australiaâ€™s leading biological scientists Mitchell was appointed an Officer in the Order of Australia. He has been an advisor on innovation to the Victorian, Commonwealth, Tasmanian and Northern Territory Governments.
Michael John Taylor AO BAgSC DipAgEcon FTSE
Mike Taylor is currently a Director of the Public Transport Development Authority and the Country Fire Authority. Formerly the Secretary to Australiaâ€™s Department of Infrastructure, Transport and Regional Services and Secretary, Department of Agriculture, Fisheries & Forestry. As a result he has been extensively involved in negotiating International, Commonwealth, State and industry agreements on a wide range of transport, security, regional development, water, energy, minerals, agricultural, food, forestry, fisheries, environmental and sustainable natural resource management issues. Mike has chaired international negotiations, meetings, delegations, projects, policy and trade development work in Asia, North America and Europe.
Peter R Turvey BA/LLB, MAICD
Former Executive Vice President Licensing and Company Secretary of CSL Limited Peter Turvey had responsibility for the protection and licensing of CSL’s intellectual property. Among the many licensing deals he was involved with, the most significant included the Gardasil license to Merck & Co., the licensing of the IscomatrixÂ® adjuvant platform technology to the worldâ€™s leading vaccine manufacturers, and establishment of the P.gingivalis vaccine technology collaboration between the CRC for Oral Health and Sanofi-Pasteur.
Maria Deveson Crabbe
Maria is an experienced CEO with over 20 years of expertise spanning across the corporate, private industry and social enterprise sectors. Maria has achievements in business start-ups, new business development and in driving innovation and organisational growth in well-established organisations; with strengths in marketing and brand strategy, operations, service delivery, FMCG and supply chain improvement.â€¨â€¨ Maria was the Founding CEO of Aussie Bodies. Under her leadership, Aussie Bodies achieved its number one status within the sports nutrition FMCG category. As CEO of Marie Stopes International Australia, she launched the not for profit pharmaceutical company, MS Health and was the driving force behind the successful registration of RU486 by the Therapeutic Goods Administration. â€¨â€¨As CEO of MSIâ€™s Australian operations, Maria led a change management process to integrate Australian clinic and pharmaceutical operations. She designed a corporate social responsibility model that ensures a percentage of operational profits are donated to program activities, with donations scaling up substantially over the past few years. As Regional Director Maria is accountable for operations in the Philippines, Vietnam, Myanmar, PNG, Timor Leste, Cambodia, China and Mongolia.â€¨â€¨ Maria won the 2014 Telstra Business Women Award for Community and Government (Victoria) and the 2014 Australian Financial Review’s 100 Women of Influence.